SEC Form 4 · accession 0000904454-17-000442
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Blair
Director
Period of report
Jun 8, 2017
Accepted (ET)
Jun 12, 2017 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy)F1 | $59.56 | Jun 8, 2017 | A | 10,000 | A | — | Jun 8, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option vests over 12 months in equal monthly installments on each monthly anniversary of the date of grant, beginning on 07/08/2017 and ending on 06/08/2018.